BindingDB logo
myBDB logout

BDBM50451118 CHEMBL2114978

SMILES: Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2cc(ccc2C[C@H]1C(O)=O)-c1ccc(F)cc1

InChI Key: InChIKey=ZHBMQILIPHSQJF-DQEYMECFSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50451118   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM50451118
PNG
(CHEMBL2114978)
Show SMILES Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2cc(ccc2C[C@H]1C(O)=O)-c1ccc(F)cc1
Show InChI InChI=1S/C27H27FN2O4/c1-15-9-22(31)10-16(2)23(15)13-24(29)26(32)30-14-20-11-18(17-5-7-21(28)8-6-17)3-4-19(20)12-25(30)27(33)34/h3-11,24-25,31H,12-14,29H2,1-2H3,(H,33,34)/t24-,25-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.80n/an/an/an/an/an/a



AstraZeneca R&D Montréal

Curated by ChEMBL


Assay Description
Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin II


Bioorg Med Chem Lett 10: 167-70 (2000)


Article DOI: 10.1016/s0960-894x(99)00652-6
BindingDB Entry DOI: 10.7270/Q2RV0MXM
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM50451118
PNG
(CHEMBL2114978)
Show SMILES Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2cc(ccc2C[C@H]1C(O)=O)-c1ccc(F)cc1
Show InChI InChI=1S/C27H27FN2O4/c1-15-9-22(31)10-16(2)23(15)13-24(29)26(32)30-14-20-11-18(17-5-7-21(28)8-6-17)3-4-19(20)12-25(30)27(33)34/h3-11,24-25,31H,12-14,29H2,1-2H3,(H,33,34)/t24-,25-/m0/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 587n/an/an/an/an/an/a



AstraZeneca R&D Montréal

Curated by ChEMBL


Assay Description
Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824


Bioorg Med Chem Lett 10: 167-70 (2000)


Article DOI: 10.1016/s0960-894x(99)00652-6
BindingDB Entry DOI: 10.7270/Q2RV0MXM
More data for this
Ligand-Target Pair
Kappa-type opioid receptor


(Homo sapiens (Human))
BDBM50451118
PNG
(CHEMBL2114978)
Show SMILES Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2cc(ccc2C[C@H]1C(O)=O)-c1ccc(F)cc1
Show InChI InChI=1S/C27H27FN2O4/c1-15-9-22(31)10-16(2)23(15)13-24(29)26(32)30-14-20-11-18(17-5-7-21(28)8-6-17)3-4-19(20)12-25(30)27(33)34/h3-11,24-25,31H,12-14,29H2,1-2H3,(H,33,34)/t24-,25-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 7.56E+3n/an/an/an/an/an/a



AstraZeneca R&D Montréal

Curated by ChEMBL


Assay Description
Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYN


Bioorg Med Chem Lett 10: 167-70 (2000)


Article DOI: 10.1016/s0960-894x(99)00652-6
BindingDB Entry DOI: 10.7270/Q2RV0MXM
More data for this
Ligand-Target Pair